Fan Zou

机构：Beijing Tongren Hospital, Pennsylvania State University · ORCID：0000-0003-3765-1176

发表论文 61 篇 · 总被引 1884 次 · h-index 22

代表论文

• Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins (2023 · 癌症：英文版 · 被引 50)
• Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment (2023 · Molecular Therapy — Oncolytics · 被引 35)
• Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy (2023 · World Journal of Surgical Oncology · 被引 29)
• AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2 (2024 · Journal of Translational Medicine · 被引 27)
• EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression (2024 · Journal of Translational Medicine · 被引 23)
• From genomic spectrum of NTRK genes to adverse effects of its inhibitors, a comprehensive genome-based and real-world pharmacovigilance analysis (2024 · Frontiers in Pharmacology · 被引 10)